GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma

NCT03294954 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

GENETIC: GINAKIT Cells
BIOLOGICAL: GINAKIT cells + Etanercept

Sponsor

Baylor College of Medicine

Collaborators

[object Object]